Global Soft Tissue Allografts Market Size By Application (Dentistry, Wound Care, Orthopedic), By Product Type (Dental Allograft, Tendon Allograft, Cartilage Allograft), By End User (Hospitals, Aesthetic Centres, Orthopedic Clinics), By Geographic Scope And Forecast

Soft Tissue Allografts Market Size And Forecast

Soft Tissue Allografts Market size was valued at USD 3.96 Billion in 2022 and is projected to reach USD 6.27 Billion by 2030, growing at a CAGR of 5.90% from 2023 to 2030.

With the rising number of sports injuries, the requirement for tissue reconstruction is on the rise which increases the demand for soft tissue allografts. These factors when integrated, drive the market growth for the Soft Tissue Allografts Market. The Global Soft Tissue Allografts Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Soft Tissue Allografts Market Definition

Tissue (Soft) Allografts are used to treat deformities and injuries in patients who have suffered musculoskeletal injuries, severe burns, tissue tears as a result of accidents, solid organ transplantation, and other conditions. As a result, soft tissue allografts are used in soft tissue reconstructive procedures for rip ligaments, spinal injuries, knee surgeries, and other soft tissue injuries. Autografts, in which soft tissue was collected from the body of the patient, such as the legs, for tissue reconstruction, resulted in more discomfort and healing, whereas soft tissue allografts employ soft tissue from a donor, resulting in very little pain and retrieval.

Soft tissue allografts go through a rigorous screening process to ensure compatibility with the patient during the tissue reconstruction process. It goes through a three-stage screening process that includes tissue preparation, laboratory testing, and donor screening. According to National Center for Biotechnology Information. (NCBI), The most often utilized transplant currently is a cortico-cancellous allograft. They have no osteoinductive or osteogenic characteristics and are solely osteoconductive.

These grafts can be manufactured as entire sections, such as femoral head/neck rings, which have typically been utilized for interbody fusion, or as chips for void-filling or posterolateral fusion. The most typical application of cortical allograft is as a mechanical strut graft, while cancellous allograft is employed as an osteoconductive scaffold for bone growth. DBM is made from human allografts and is made by extracting intrinsic minerals with acid to generate an osteoconductive organic matrix with varying amounts of proteins to aid in osteoinduction. DBM is made up of collagen, non-collagenous proteins, growth hormones, a little amount of calcium phosphate mineral (1%–6%), and some cellular detritus.

An Achilles tendon allograft with a calcaneus bone block was employed in the surgical procedure for extensor mechanism repair. The calcaneus bone block was fashioned to fit into a trapezoidal tibial tubercle recipient site for patellar tendon restoration. A single countersunk cortical lag screw was used to secure the bone block to the tibial location. To fix the allograft distally, two suture anchors were put directly proximal to the tubercle, threaded through the Achilles tendon, and knotted.

Global Soft Tissue Allografts Market Overview

With the advent of high-end technology and aiding systems, several sophisticated orthopedic surgeries, spinal surgeries, and other procedures are now possible thanks to improvements in the healthcare sector. As a result of this, there has been an increase in the number of orthopedic procedures, as well as an increase in chronic diseases such as arthritis, as a result of the aging population, obesity, lack of physical activity, and other factors. This has resulted in a rise in the demand for soft tissues in tissue reconstruction procedures.

Also, the aging population, combined with an increase in death rates due to vaccination availability, improved knowledge of personal cleanliness, medical advancement, and other factors, has raised the demand for dental implants. Typically, the elderly population has the highest proportion of dental treatments and has a higher demand for soft tissue dental implants. Due to these characteristics, there is a surge in demand for generating new tissues, and most individuals prefer soft tissue allografts over autograft operations to assure less pain and a faster recovery time during treatment. Furthermore, as the number of sports injuries rises, so does the need for tissue repair, which drives up the demand for soft tissue allografts.

When these variables are combined, the Soft Tissue Allografts Market grows at a rapid pace. Although the use of soft tissue allografts demands a thorough screening test, failure to do so would lead to infection, disease exposure, and bacterial contamination. These issues limit the market for soft tissue allografts. Cartilage allografts are important components in orthopedic surgery treatments like joint reconstruction. Cartilage graft transplantation is a common treatment for chondral and osteochondral diseases, especially in the knee. These procedures can help people with cartilage disease in their joints enhance their quality of life and relieve their symptoms. Operating in the industry Soft Tissue Allografts Market will begin to recognize the potential for opportunities that will boost expansion as the phrase soft tissue allograft gains traction and the number of procedures increases.

Soft tissue transplant demand is significantly higher than supply. The ‘ease of treatment’ in allografts attracts their attention, even when a healthcare practitioner educates a patient about both options autograft and allograft as well as the benefits and drawbacks of each. An autograft prolongs the patient’s suffering and healing period since soft tissue from the patient’s own body must be taken out. A donor is used to obtain allograft tissue, eliminating the need for further recuperation time. When technology makes the current allograft approach more comfortable and effective, patients will stop considering autografts as a treatment option. Patients will start to have more confidence in soft tissue allografts as businesses and medical facilities utilize strict screening procedures to address worries about bacterial contamination and diseases.

Global Soft Tissue Allografts Market Segmentation Analysis

The Global Soft Tissue Allografts Market is Segmented on the basis of Application, Product Type, End User, And Geography.

Soft Tissue Allografts Market, By Application

•  Dentistry
•  Wound Care
•  Orthopedic
•  Others

Based on Application, The market is bifurcated into Dentistry, Wound Care, Orthopedic, and Others. Acellular dermal matrix is still being used by surgeons in hospitals around the country to treat patients who need reconstruction after procedures including breast resection, head/neck dissection, and severe burns. Acellular dermal matrix was first used in dentistry as dental Allograft over a decade ago and has been shown to be safe and effective in treating dental soft tissue problems in several research investigations.

Our surgeons can execute various soft tissue treatments in a minimally invasive manner while giving predictable and aesthetic results by using an acellular dermal matrix as an alternative to traditional tissue harvesting methods. Allograft surgery eliminates the necessity for roof-of-mouth surgery, reducing post-operative discomfort and allowing many patients to recuperate from soft tissue grafting treatments without pain.

Soft Tissue Allografts Market, By Product Type

•  Dental Allograft
•  Tendon Allograft
•  Cartilage Allograft
•  Meniscus Allograft
•  Others

Based on Product Type, The market is bifurcated into Dental Allograft, Tendon Allograft, Cartilage Allograft, Meniscus Allograft, and Others. After an extraction, a dental bone transplant is most commonly done to preserve the edentulous area so that an implant can be implanted. After extractions, ridge augmentation and socket preservation are performed to minimize substantial bone loss and abnormalities.

Ridge Augmentation can restore the height and width of missing bone and limit further degradation by using a bone graft. Socket Preservation involves filling an extraction socket with a bone or bone substitute to increase the success rate of future procedures such as dental implants, dentures, or bridges. The maxillary sinus floor may fall out when upper posterior teeth are extracted, leaving just a little quantity of bone.

Soft Tissue Allografts Market, By End User

•  Hospitals
•  Aesthetic Centres
•  Orthopedic Clinics
•  Dental Clinics
•  Others

Based on End User, The market is bifurcated into Hospitals, Aesthetic Centres, Orthopedic Clinics, Dental Clinics, and Others. Soft tissue allograft is utilized by specialists in clinics for knee and ankle joint reconstruction, meniscal replacement, reconstruction due to cancer or trauma, ridge augmentation in dental treatments, shoulder repair, spinal fusion, and urological operations. Anterior cruciate ligament (ACL) repair is one of the most common orthopedic procedures, with more than 200,000 procedures performed each year and a rate of 30 to 78 per 100,000 persons.

Over time, ACL reconstruction techniques have progressed from open surgeries that limited postoperative weight-bearing and range of motion to arthroscopically aided single-incision approaches that allowed for full weight-bearing and early range of motion. Similarly, there has been a paradigm shift in graft selection.

Soft Tissue Allografts Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

On the basis of Geography, The Global Soft Tissue Allografts Market is classified into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The region of Asia Pacific is anticipated to expand most quickly. The largest share of the market will be in North America. thanks to Soft tissue allografts are the main kind of replacement tissue used during knee surgery to fix weak ligaments, osteochondral abnormalities, and torn menisci. Additionally, there is a strong need for allografts for the repair of soft tissue since a stable knee is required to prevent future ligament damage and to restore knee functions. Allografts are superior to autografts in musculoskeletal reconstructions such as the replacement of the anterior cruciate ligament.

Key Players

The “Global Soft Tissue Allografts Market” study report will provide valuable insight with an emphasis on the global market including some of the major players such as Lattice Biologics Ltd, CONMED Corporation, Alliqua BioMedical, Arthrex Inc., Globus Medical Inc., Xtant Medical, Zimmer Biomet, Integra LifeSciences Corporation, Organogenesis Inc, Straumann Holding AG., and Direct Biologics.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In July 2022, The quadricep tendon has been added to the AlloConnexTM range of tendons, ligaments and fascia by AlloSource, one of the largest allograft providers in the United States. AlloSource develops cutting-edge cellular and tissue allografts to assist surgeons in healing their patients. Recently, it has become more common to repair ligaments using a quadricep tendon. AlloSource’s AlloConnex quadricep tendon, which is offered with or without the bone block for different surgical approaches, is a reliable solution for cruciate ligament surgeries.
• In Jan 2021, Direct Biologics, LLC has made placenta-based sheet allografts called AmnioWrap available for clinical use. A three-layer graft called AmnioWrap may be applied to both fresh and old wounds.
• In Feb 2020, Integra LifeSciences Holding Corporation has introduced AmnioExcel Plus Placental Allograft Membrane, the newest wound care product to improve soft tissue healing.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Soft Tissue Allografts Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in the Global Soft Tissue Allografts Market, gauge the attractiveness of a certain sector, and assess investment possibilities.